America's Public Companies -DRIVING INNOVATION- Building Value
Nicole Levey Hunt
Journalist Nicole Levey Hunt reports for Itsaboutfinance.com, from the Nasdaq Market Site, the New York Stock Exchange, the American Stock Exchange and Washington, D.C.. Ms. Hunt developed a unique perspective on business while working in the area of leadership and organizational development. She spent several years working as a project manager and researcher for the consulting firm of Vision and Values, which consults on leadership and organizational development. As project manager, she worked with organizational teams helping to facilitate their change initiatives. Her work focused on training and group dialogues.
In addition, Ms. Hunt spent one year in the interior of China teaching English and developing the English curriculum. During this time, she had the unique opportunity to immerse herself not only in the language and culture of China, but also to observe first hand business development in mainland China.
She attended Eugene Lang College and The New School University in New York City and currently resides in Manhattan, New York.
Nicole welcomes your comments and market questions.
NHunt@itsaboutfinance.com
Watch Us! ItsAboutFinance.com is featured daily at the NASDAQ Market.
Samaritan Pharmaceuticals is a drug development company involved with innovative therapeutics' for AIDS, Alzheimer's, Cancer and Heart disease. In collaboration with Georgetown University, the company is advancing eight promising compounds.
Summit Environmental is involved in the marketing and distribution of biodegradable, non-toxic chemical products and fire suppression agents, which the patent and intellectual property rights are held by Summit.
Homeland Integrated Security Systems owns proprietary technology and has the rights to use patents to some of the most innovative and sophisticated seaport security products. Their target market is the 361 commercial seaports in the US which are vulnerable to criminal penetration.
Health Discovery Corporation is uniquely positioned in the field of pattern recognition. The company is focused on commercializing its intellectual property in genomic and proteomic biomarker discovery, medical imaging, diagnostics, and pharmaceutical advancements in personalized medicine.
